These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15026558)

  • 1. Calcitriol in cancer treatment: from the lab to the clinic.
    Beer TM; Myrthue A
    Mol Cancer Ther; 2004 Mar; 3(3):373-81. PubMed ID: 15026558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of weekly high-dose calcitriol based therapy for prostate cancer.
    Beer TM
    Urol Oncol; 2003; 21(5):399-405. PubMed ID: 14670552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for the development and current status of calcitriol in androgen-independent prostate cancer.
    Beer TM; Myrthue A; Eilers KM
    World J Urol; 2005 Feb; 23(1):28-32. PubMed ID: 15668801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D compounds: clinical development as cancer therapy and prevention agents.
    Trump DL; Muindi J; Fakih M; Yu WD; Johnson CS
    Anticancer Res; 2006; 26(4A):2551-6. PubMed ID: 16886663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitriol in the treatment of prostate cancer.
    Beer TM; Myrthue A
    Anticancer Res; 2006; 26(4A):2647-51. PubMed ID: 16886675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor activity of calcitriol: pre-clinical and clinical studies.
    Trump DL; Hershberger PA; Bernardi RJ; Ahmed S; Muindi J; Fakih M; Yu WD; Johnson CS
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):519-26. PubMed ID: 15225831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy.
    Trump DL; Deeb KK; Johnson CS
    Cancer J; 2010; 16(1):1-9. PubMed ID: 20164683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weekly high-dose calcitriol and docetaxel in advanced prostate cancer.
    Beer TM; Hough KM; Garzotto M; Lowe BA; Henner WD
    Semin Oncol; 2001 Aug; 28(4 Suppl 15):49-55. PubMed ID: 11685729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of vitamin D in cancer prevention and treatment.
    Krishnan AV; Trump DL; Johnson CS; Feldman D
    Endocrinol Metab Clin North Am; 2010 Jun; 39(2):401-18, table of contents. PubMed ID: 20511060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase I trial of pulse calcitriol in patients with refractory malignancies: pulse dosing permits substantial dose escalation.
    Beer TM; Munar M; Henner WD
    Cancer; 2001 Jun; 91(12):2431-9. PubMed ID: 11413535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells.
    Golovko O; Nazarova N; Tuohimaa P
    Life Sci; 2005 Jun; 77(5):562-77. PubMed ID: 15904673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASCENT: the androgen-independent prostate cancer study of calcitriol enhancing taxotere.
    Beer TM
    BJU Int; 2005 Sep; 96(4):508-13. PubMed ID: 16104901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of calcitriol in cancer prevention and treatment.
    Ma J; Ma Z; Li W; Ma Q; Guo J; Hu A; Li R; Wang F; Han S
    Curr Med Chem; 2013; 20(33):4121-30. PubMed ID: 23895685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized study of high-dose pulse calcitriol or placebo prior to radical prostatectomy.
    Beer TM; Myrthue A; Garzotto M; O'hara MF; Chin R; Lowe BA; Montalto MA; Corless CL; Henner WD
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2225-32. PubMed ID: 15598784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D-related therapies in prostate cancer.
    Johnson CS; Hershberger PA; Trump DL
    Cancer Metastasis Rev; 2002; 21(2):147-58. PubMed ID: 12465754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of combined treatment on head and neck human cancer cell lines with novel analogs of calcitriol and cytostatics.
    Wietrzyk J; Milczarek M; Kutner A
    Oncol Res; 2007; 16(11):517-25. PubMed ID: 18306931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative role of vitamin D and its analogs--a brief overview.
    Banerjee P; Chatterjee M
    Mol Cell Biochem; 2003 Nov; 253(1-2):247-54. PubMed ID: 14619976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells.
    Peehl DM; Seto E; Hsu JY; Feldman D
    J Urol; 2002 Oct; 168(4 Pt 1):1583-8. PubMed ID: 12352462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
    Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.